Hollsteen
← Flex

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: $2.5B · 10-Q 0001628280-15-005450 filed Jul 27, 2015Equity incl. NCI · Q2 FY2016: $2.5B · 10-Q 0001628280-15-007847 filed Oct 26, 2015Equity incl. NCI · Q3 FY2016: $2.6B · 10-Q 0001628280-16-010628 filed Feb 1, 2016Equity incl. NCI · Q4 FY2016: $2.6B · 10-K 0001628280-16-016576 filed May 20, 2016Equity incl. NCI · Q1 FY2017: $2.7B · 10-Q 0001628280-16-017813 filed Jul 27, 2016Equity incl. NCI · Q2 FY2017: $2.6B · 10-Q 0000866374-16-000007 filed Oct 31, 2016Equity incl. NCI · Q3 FY2017: $2.6B · 10-Q 0000866374-17-000002 filed Jan 27, 2017Equity incl. NCI · Q4 FY2017: $2.7B · 10-K 0000866374-17-000005 filed May 16, 2017Equity incl. NCI · Q1 FY2018: $2.8B · 10-Q 0000866374-17-000008 filed Aug 1, 2017Equity incl. NCI · Q2 FY2018: $2.9B · 10-Q 0000866374-17-000012 filed Oct 30, 2017Equity incl. NCI · Q3 FY2018: $3.0B · 10-Q 0000866374-18-000003 filed Jan 29, 2018Equity incl. NCI · Q4 FY2018: $3.0B · 10-K 0000866374-18-000007 filed Jun 14, 2018Equity incl. NCI · Q1 FY2019: $3.1B · 10-Q 0000866374-18-000010 filed Aug 2, 2018Equity incl. NCI · Q2 FY2019: $3.2B · 10-Q 0000866374-18-000013 filed Nov 2, 2018Equity incl. NCI · Q3 FY2019: $3.1B · 10-Q 0000866374-19-000003 filed Feb 6, 2019Equity incl. NCI · Q4 FY2019: $3.0B · 10-K 0000866374-19-000006 filed May 21, 2019Equity incl. NCI · Q1 FY2020: $3.0B · 10-Q 0000866374-19-000010 filed Jul 26, 2019Equity incl. NCI · Q2 FY2020: $2.8B · 10-Q 0000866374-19-000013 filed Oct 30, 2019Equity incl. NCI · Q3 FY2020: $2.9B · 10-Q 0000866374-20-000003 filed Jan 31, 2020Equity incl. NCI · Q4 FY2020: $2.8B · 10-K 0000866374-20-000009 filed May 28, 2020Equity incl. NCI · Q1 FY2021: $2.9B · 10-Q 0000866374-20-000012 filed Aug 5, 2020Equity incl. NCI · Q2 FY2021: $3.1B · 10-Q 0000866374-20-000030 filed Nov 2, 2020Equity incl. NCI · Q3 FY2021: $3.4B · 10-Q 0000866374-21-000019 filed Jan 29, 2021Equity incl. NCI · Q4 FY2021: $3.4B · 10-K 0000866374-21-000030 filed May 19, 2021Equity incl. NCI · Q1 FY2022: $3.5B · 10-Q 0000866374-21-000043 filed Jul 30, 2021Equity incl. NCI · Q2 FY2022: $3.5B · 10-Q 0000866374-21-000062 filed Oct 29, 2021Equity incl. NCI · Q3 FY2022: $3.7B · 10-Q 0000866374-22-000016 filed Feb 4, 2022Equity incl. NCI · Q4 FY2022: $4.1B · 10-K 0000866374-22-000035 filed May 20, 2022Equity incl. NCI · Q1 FY2023: $4.1B · 10-Q 0000866374-22-000052 filed Jul 29, 2022Equity incl. NCI · Q2 FY2023: $4.2B · 10-Q 0000866374-22-000074 filed Oct 31, 2022Equity incl. NCI · Q3 FY2023: $4.5B · 10-Q 0000866374-23-000007 filed Jan 27, 2023Equity incl. NCI · Q4 FY2023: $5.7B · 10-K 0000866374-23-000028 filed May 19, 2023Equity incl. NCI · Q1 FY2024: $5.8B · 10-Q 0000866374-23-000058 filed Jul 31, 2023Equity incl. NCI · Q2 FY2024: $6.4B · 10-Q 0000866374-23-000066 filed Oct 30, 2023Equity incl. NCI · Q3 FY2024: $6.4B · 10-Q 0000866374-24-000012 filed Feb 2, 2024Equity incl. NCI · Q4 FY2024: $5.3B · 10-K 0000866374-24-000021 filed May 17, 2024Equity incl. NCI · Q1 FY2025: $5.0B · 10-Q 0000866374-24-000034 filed Jul 26, 2024Equity incl. NCI · Q2 FY2025: $5.0B · 10-Q 0000866374-24-000053 filed Oct 31, 2024Equity incl. NCI · Q3 FY2025: $5.0B · 10-Q 0000866374-25-000008 filed Jan 31, 2025Equity incl. NCI · Q4 FY2025: $5.0B · 10-K 0000866374-25-000027 filed May 21, 2025Equity incl. NCI · Q1 FY2026: $5.1B · 10-Q 0000866374-25-000043 filed Jul 25, 2025Equity incl. NCI · Q2 FY2026: $5.0B · 10-Q 0000866374-25-000051 filed Oct 31, 2025Equity incl. NCI · Q3 FY2026: $5.1B · 10-Q 0000866374-26-000005 filed Feb 6, 2026Equity incl. NCI · Q4 FY2026: $5.1B · 10-K 0000866374-26-000012 filed May 20, 2026Equity incl. NCI · Q1 FY2027: $5.5B · 10-Q 0000866374-26-000030 filed Jul 31, 20265,3255,5002,4886,445Q1 FY2016Q1 FY2027Q4 FY2024
Q4 FY2024
5,325$M
All values (45)
PeriodValue ($M)Status
Q1 FY20275,500reported
Q4 FY20265,144reported
Q3 FY20265,121reported
Q2 FY20265,035reported
Q1 FY20265,089reported
Q4 FY20255,002reported
Q3 FY20254,992reported
Q2 FY20255,003reported
Q1 FY20254,996reported
Q4 FY20245,325reported
Q3 FY20246,445reported
Q2 FY20246,356reported
Q1 FY20245,786reported
Q4 FY20235,706reported
Q3 FY20234,505reported
Q2 FY20234,180reported
Q1 FY20234,091reported
Q4 FY20224,129reported
Q3 FY20223,655reported
Q2 FY20223,514reported
Q1 FY20223,508reported
Q4 FY20213,436reported
Q3 FY20213,381reported
Q2 FY20213,115reported
Q1 FY20212,940reported
Q4 FY20202,831reported
Q3 FY20202,899reported
Q2 FY20202,806reported
Q1 FY20203,002reported
Q4 FY20192,972reported
Q3 FY20193,078reported
Q2 FY20193,170reported
Q1 FY20193,109reported
Q4 FY20183,019reported
Q3 FY20182,980reported
Q2 FY20182,872reported
Q1 FY20182,810reported
Q4 FY20172,678reported
Q3 FY20172,641reported
Q2 FY20172,604reported
Q1 FY20172,667reported
Q4 FY20162,606reported
Q3 FY20162,578reported
Q2 FY20162,456reported
Q1 FY20162,488reported

CSV with all sources · Technical ID: equity_total

More metrics for Flex
Sources & calculation
Value
$5.3B
Period
Q4 FY2024, ended Mar 31, 2024 · as of Mar 31, 2024 (balance as of date, not a sum)
Source
10-K, filed May 17, 2024 · 0000866374-24-000021
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$5.3BMay 17, 202410-K 0000866374-24-000021reported · confidence 1. · current